Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-30

Clinical Trial Update: Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating Finacea 15% gel and brimonidine 0.33% gel for rosacea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine tartrate 0.33% Gel (Mirvaso) (brimonidine tartrate)
  • Finacea 15% Gel (azelaic acid)

Snippet

Sponsor: Derm Research, PLLC | Conditions: Acne Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2015-09-30